Pancreatic cancer accounts for a disproportionate share of cancer mortality, composing only 3% of cancer diagnoses yet 7% of cancer deaths. With an increasing incidence and a stable mortality rate, the burden from this disease is rising. Obviously, efforts to improve outcomes are greatly needed. While progress can come from advancements in prevention, diagnosis, and treatment, given known pancreatic cancer health inequities, assuring that all patients obtain the best outcome possible is also of utmost importance.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Gold JS. Linking Disparities to Outcomes in Pancreatic Cancer: Inching Toward Answers. JAMA Surg. 2020;155(2):e195082. doi:10.1001/jamasurg.2019.5082
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.